GSE171538
Combination of EZH2 inhibitor and STING agonist in melanoma cell lines
In order to better understand the effects of combination treatment with EZH2 inhibitor and STING agonist in human melanoma cells, RNA sequencing was performed to explore transcriptome alteration. Overall design: RNA sequencing in 2 melanoma cell lines with GSK126 or/and di-ABZI treatment